Evidence map›Paper›PMID 35162503›Full record

ArticleInternational journal of environmental research and public health2022

Mitigating the Health Effects of Aqueous Cr(VI) with Iron-Modified Biochar.

Zhihong Zheng, Xiaohan Duan

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Zhihong ZhengSchool of Water Conservancy, North China University of Water Resources and Electric Power, Zhengzhou 450046, China.
Xiaohan DuanSchool of Water Conservancy, North China University of Water Resources and Electric Power, Zhengzhou 450046, China.ORCID 0000-0002-6317-5997

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A large amount of chromium (Cr) has entered the natural environment from the wastewater and waste residues, and the hexavalent (Cr(VI)) is highly poisonous, threatening the ecological environment and human health directly. In this study, iron-modified biochar was prepared using honeysuckle residue as raw material and the ferric chloride impregnation method. Batch Cr(VI) adsorption experiments were carried out using the modified honeysuckle-derived biochar (MHDB) as an adsorbent. The results indicate that a pH of 2 was best for the adsorption removal of Cr(VI) in the initial pH range of 2-10. The adsorption kinetic data fitted the pseudo-second-order model best out of the two models, and the Langmuir model was better than the Freundlich model to describe the adsorption process. Thermodynamic analysis indicated that the adsorption process of Cr(VI) on MHDB had an endothermic and spontaneous nature, and the increasing temperature was conducive to the adsorption. The main mechanisms of Cr(VI) adsorption might be the physical adsorption (electrostatic interactions) and chemical adsorption (ion exchange, the reduction of Cr(VI) to Cr(III)). The efficient adsorption of Cr(VI) makes MHDB a potential material for Cr(VI)-containing wastewater treatment. This study provides a feasible adsorption material for mitigating the environmental hazards of chromium, which has a certain reference value for protecting environmental health.

Indexed as

IronWater Pollutants, ChemicalAdsorptionCharcoalChromiumHumansHydrogen-Ion ConcentrationKineticsbiocharCharcoalChromiumchromium hexavalent ionIronWater Pollutants, Chemicaladsorptionchromiumenvironmental healthferric chloridetraditional Chinese medicine residual

Identifiers

PMID35162503
PMCPMC8835030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.